^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    imvotamab (IGM-2323)

    i
    Company:
    IGM Biosciences
    Drug class:
    CD20 inhibitor, CD3 agonist
    Related drugs: